Arnason; Barry G.W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Arnason; Barry G.W..The latest application filed is for "polymeric immunoglobulin fusion proteins that target low-affinity fcγ receptors".

Company Profile

1.7.8

Arnason; Barry G.W. - Chicago IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymeric Immunoglobulin Fusion Proteins That Target Low-affinity Fcγ Receptors App 20210188975 - Arnason; Barry G.W. ; et al.	2021-06-24
Fusion proteins and their related methods App 20190055310 - Arnason; Barry G.W. ; et al.	2019-02-21
Fusion proteins and their related methods App 20160194395 - Arnason; Barry G.W. ; et al.	2016-07-07
Nucleic acids related to fusion proteins Grant 9,127,063 - Arnason , et al. September 8, 2	2015-09-08
Method of using fusion proteins Grant 8,986,698 - Arnason , et al. March 24, 2	2015-03-24
Nucleic acids related to fusion proteins App 20140087422 - Arnason; Barry G. W. ; et al.	2014-03-27
Methods and compositions involving polymeric immunoglobulin fusion proteins Grant 8,163,289 - Arnason , et al. April 24, 2	2012-04-24
POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS App 20110195067 - Arnason; Barry G. W. ; et al.	2011-08-11
Polymeric immunoglobulin fusion proteins that target low affinity Fc.gamma.Receptors Grant 7,897,729 - Arnason , et al. March 1, 2	2011-03-01
POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS App 20090117133 - Arnason; Barry G.W. ; et al.	2009-05-07
Polymeric immunoglobulin fusion proteins that target low-affinity Fc.gamma.receptors Grant 7,511,121 - Arnason , et al. March 31, 2	2009-03-31
Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins App 20080292704 - Arnason; Barry G.W. ; et al.	2008-11-27
Polymeric immunoglobulin fusion proteins that target low-affinity fcyreceptors App 20030161826 - Arnason, Barry G. W. ; et al.	2003-08-28
Use of .beta.-adrenergic agonists to treat patients with demyelinating or autoimmune diseases Grant 5,264,459 - Chelmicka-Schorr , et al. November 23, 1	1993-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.